Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Hematology in Clinical Practice
MENU
Shortcuts Submit an article Author Guidelines Ahead Of Print Reviewers 2021

Vol 9, Supp. A (2018)

Date published: 2019-06-07

Table of Contents

open access

CASE REPORTS

Treatment of patients with chronic myelogenous leukemia with tyrosine kinase inhibitors — skirmishes with side effects of medications

Justyna Gil

Case report

DOI: 10.5603/Hem.2018.0008
PDF

Successful nilotinib treatment in a patient with chronic myelogenous leukemia after failure of treatment with two tyrosine kinase inhibitors due to intolerance and resistance

Edyta Paczkowska

Case report

DOI: 10.5603/Hem.2018.0009
PDF

Nilotinib treatment of a patient with chronic myelogenous leukemia after previous failure to imatinib and dasatinib

Marzena Wątek, Ewa Wasińska, Sylwia Kościołek-Zgódka, Marcin Pasiarski, Stanisław Góźdź

Case report

DOI: 10.5603/Hem.2018.0010
PDF

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl